DOC: Several Stillwater prison staff taken to hospital after suspected exposure to synthetic marijuana
Stillwater were taken to the hospital Thursday for evaluation after an inmate smoked suspected synthetic marijuana and then a ...
Synthetic Biology Market to Grow by USD 55.60 billion (2024-2028), AI Driven Innovations Boost Adoption and Market Revenue - Technavio Report
Report with the AI impact on market trends- The global synthetic biology market size is estimated to grow by USD 55.60 ...
Nine Stillwater prison staffers treated after exposure to synthetic drug used by inmates
Nine staff members at the Minnesota Correctional Facility in Stillwater were treated at a hospital and released Thursday ...
'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability
Cellular immunotherapy, a leading form of cancer treatment, enlists the "warriors" of our immune system, our T-cells, in the ...
FierceBiotech1d
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform
GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...
The Pharma Letter20h
GCTx launches with bold cell therapy claim
GC Therapeutics (GCTx) has launched with its TFome platform, developed by scientists at Harvard and the Wyss Institute, ...
KFGO15h
Minnesota prison placed in lockdown after staff was exposed to apparent synthetic drug
BAYPORT, Minn. (KFGO) – Stillwater state prison southeast of the Twin Cities was placed on temporary lockdown Thursday after ...
minnesotasnewcountry1h
Minnesota Prison Staff Possibly Exposed To Synthetic Drugs
A Minnesota prison could be on lockdown through Saturday after staff became ill from what was described by the Minnesota ...
Synthetic Blood Stem Cells Herald New Era in Bone Marrow Transplants
Researchers have achieved a significant advancement by developing lab-generated blood stem cells that mirror those found in ...
Business Wire1d
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy
“GCTx’s cell programming platform represents a major scientific advancement,” said George Church, Ph.D., professor of genetics at Harvard Medical School, core faculty member and synthetic biology lead ...